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ABSTRACT 
 
Peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) promotes the 
expression of oxidative enzymes in skeletal muscle. We hypothesized that activation of 
the p38 MAPK (mitogen-activated protein kinase) in response to exercise was 
associated with exercise-induced PGC-1α and respiratory enzymes expression and 
aimed to demonstrate this under the physiological level. We subjected mice to a single 
bout of treadmill running and found that the exercise induced a biphasic increase in the 
expression of respiratory enzymes mRNA. The second phase of the increase was 
accompanied by an increase in PGC-1α protein, but the other was not. Administration 
of SB203580 (SB), an inhibitor of p38 MAPK, suppressed the increase in PGC-1α 
expression and respiratory enzymes mRNA in both phases. These data suggest that p38 
MAPK is associated with the exercise-induced expression of PGC-1α and biphasic 
increase in respiratory enzyme mRNAs in mouse skeletal muscle under physiological 
conditions. 
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INTRODUCTION 
 
Endurance exercise increases the expression of oxidative enzymes in the mitochondria 
of skeletal muscle [1]. However, the precise mechanism by which this increase occurs is 
obscure. PGC-1α, a transcriptional coactivator cloned from a differentiated brown fat 
cell line [2], has recently been shown to play an important role in adaptive 
thermogenesis, glucose metabolism, mitochondrial biogenesis and muscle fiber type 
specialization [3]. Several lines of evidence are consistent with the notion that PGC-1α 
has a pivotal role in promoting oxidative capacity in skeletal muscle. Transient 
expression of the PGC-1α gene induces an increase in mitochondrial gene expression in 
several cell lines [2, 4-6]. Muscle-specific overexpression of PGC-1α in transgenic mice 
results in enhanced mitochondrial biogenesis and slow-twitch (type I) fiber formation[7]. 
Although endurance exercise induces PGC-1α mRNA and protein expression in rodents 
and humans [8-11], it is currently unknown whether exercise-induced 
PGC-1α expression in skeletal muscle is essential for mitochondrial protein expression 
in physiological conditions because the notion that PGC-1α induces mitochondrial 
protein expression was based on the findings of gain-of-function studies. 
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The p38 mitogen activated protein kinase (MAPK) pathway in skeletal muscle has been 
a focus of recent study in myogenic cell differentiation, glucose metabolism and energy 
expenditure [12-14]. Although exercise induces activation of p38 MAPK in rodents and 
humans, the downstream effects of the activation in skeletal muscle are currently 
unknown. Based on several previous findings, we hypothesized that activation of p38 
MAPK in response to exercise might mediate PGC-1α expression, followed by 
expression of mitochondrial protein. For example, phosphorylated p38 MAPK can 
directly stimulate transcriptional factors of the PGC-1α gene, such as ATF2 and MEF2 
[15-17]. Overexpression of MKK3E, an upstream kinase of p38 MAPK, or wild-type 
p38 isoforms stimulates PGC-1α promoter activity in C2C12 myocytes, whereas 
muscle-specific expression of MKK6E enhances PGC-1α protein expression in 
fast-twitch muscles [18]. These data suggest that p38 MAPK is associated with 
exercise-induced PGC-1α expression. However, it is uncertain whether activation of 
p38 MAPK stimulates PGC-1α gene transcription, followed by mitochondrial enzyme 
expression under physiological conditions. This is because 1) previous studies merely 
showed that exercise induced phosphorylation of p38 MAPK, or 2) the results were 
based on methodology involving overexpression. 
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In this study, we subjected mice to a single bout of treadmill running and investigated 
the effect of the exercise on expression of PGC-1α and respiratory enzymes. Then, to 
determine the effect of p38 MAPK activation on the expression of PGC-1α and 
respiratory enzymes under the physiological level, we used a pharmacological inhibitor 
of p38 MAPK, SB203580 (SB). We hypothesized that a single bout of exercise would 
induce expression of PGC-1α and respiratory enzymes through activation of p38 
MAPK in skeletal muscle, as shown in overexpression studies. 
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MATERIALS AND METHODS 
Animals 
Female ICR mice (CLEA, Tokyo, Japan) aged 10 weeks were used. Food (Oriental 
Yeast, Tokyo, Japan) and water were provided ad libitum. The room temperature was 
maintained at 22 ± 1°C with a 12-h light (07:00 to 19:00) and 12-h dark (19:00 to 
07:00) cycle. All protocols were approved by the Animal Experimental Committee of 
the University of Tsukuba. 
 
Exercise Protocols 
Mice were randomly assigned to either a non-exercised control group (n = 6) or exercise 
groups (n = 36). Six days before the experiment, all of the mice were acclimated for 
three days to a motor-driven treadmill by walking at a speed of 5-10 m/min for 15 min 
per day. Thirty-six mice then ran on the treadmill at 20 m/min for 90 min, and were 
anesthetized with an intraperitoneal injection of nembutal (0.1 mg/g body weight) 
immediately, or at 1, 3, 6, 12, or 24 h after exercise. Until anesthetization, food and 
water were provided ad libitum. Because the plantaris muscle is well recruited in 
treadmill running and has been used in several studies [8, 11, 18, 19], the muscle was 
dissected out quickly from each mouse, taking special care not to stretch it, frozen in 
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liquid nitrogen, and stored at -80°C until assay.  
 
SB203580 administration  
Forty-eight female ICR mice were divided into eight groups: control + saline, control + 
SB, immediately after running + saline, immediately after running + SB, 1 h after 
running + saline, 1 h after running + SB, 12 h after running + saline and 12 h after 
running + SB. Four groups of mice were administered SB dissolved in saline (25 mg/kg 
body weight) twice by intraperitoneal injection, 16 h and 1 h before treadmill running, 
whereas the others were administered the same volume of saline. The dose of SB 
employed in a previously reported study was used [20], and we verified its effect before 
conducting the present study. After treatment with SB or saline, the mice were run on 
the treadmill at 20 m/min for 90 min, and then immediately after, 1 h or 12 h after 
running, they were killed, and their plantaris muscles were harvested, frozen in liquid 
nitrogen, and stored at -80°C until assay. As all mice accomplished the exercise protocol, 
SB administration did not appear to affect running performance. 
 
RNA isolation 
Total RNA was extracted using the SV Total RNA Isolation System (Promega, WI, 
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USA) according to the manufacturer’s protocol. Total RNA concentration was 
determined spectrophotometrically at 260 nm.  
 
Reverse transcription and real-time PCR 
 First-strand cDNA was generated from 1μg of total RNA using ReverTra Ace 
α (TOYOBO, Osaka, Japan). Real-time PCR was performed using a 7500 Real Time 
PCR System (Applied Biosystems, CA, USA) and Power SYBR Green PCR Master 
Mix (Applied Biosystems). The PCR primers used were as: cyclophilin forward primer, 
5'-CGATGACGAGCCCTTGG-3'; reverse, 5'-TCTGCTGTCTTTGGAACTTTGTC-3'; 
cytochrome c (CYTC) forward primer, 5'- GCTTATCGGCCACCCAAGTG-3'; reverse, 
5'-GGGCTGCTGAGAGCTTGTTC-3'; cytochrome c oxidase subunit IV (COXIV) 
forward primer, 5'-TACTTCGGTGTGCCTTCGA-3'; reverse, 
5'-TGACATGGGCCACATCAG-3'; ATP synthase β subunit (ATPsynβ) forward primer, 
5'- CAGGCTATCTATGTGCCTGCTGAT-3'; reverse, 
5'-GCATCCAAATGGGCAAAGG-3', carnitine palmitoyltransferase I (CPT-I) forward 
primer, 5'-ACCACATCCGCCAAGCA-3'; reverse, 
5'-TTCCTCAGCTGTCTGTCTTGGA-3'. The PCR conditions for all genes consisted of 
one denaturing cycle at 95°C for 10 min, 40 cycles consisting of denaturing at 95°C for 
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15 s, and annealing and elongation at 60°C for 1 min. At the end of the PCR, the 
samples were subjected to dissociation curve analyses. The relative amounts of mRNA 
were determined by the standard curve method. Signals were normalized against 
cyclophilin mRNA. We also used S26 ribosomal protein as an internal control and this 
provided results similar to those when the PCR signals were normalized to cyclophilin. 
Cyclophilin and S26 mRNAs were not affected by either exercise or SB203580 (data 
not shown). All samples for each gene were run in duplicate.  
 
Western blotting  
For PGC-1α protein analysis, dissected plantaris muscles were homogenized and 
analyzed as described previously [19]. 
 
Protein kinase assay for p38 MAPK 
p38 MAPK kinase activity was determined as described previously with some 
modifications [16]. In brief, in vitro kinase assays were performed at 37 °C for 30 min 
by using 10 μl of whole-muscle lysates, 2 μg of substrate ATF-2 Fusion Protein 
(purchased from Cell Signaling) and 250 μM ATP in 40 μl kinase reaction buffer. The 
ATF-2 fragment used in these experiments was a specific substrate for p38 MAPK [21]. 
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An equivalent amount of 2× Laemmli sample buffer was added to terminate the 
reactions. Proteins were resolved with 10 % polyacrylamide gels, transfered to PVDF 
membrane, and detected by anti phospho-ATF-2 antibodies (Cell Signaling). The level 
of p38 MAPK in the cell lysates was detected by Western blotting with antibodies 
against p38 MAPK. 
 
Statistical analysis 
All data are expressed as means ± SE. The effect of treadmill running was analyzed 
using one-way ANOVA. Two-way ANOVA was used for SB203580 administration 
studies. If ANOVA indicated a significant difference, Tukey HSD was performed to 
determine the significance of the difference between means.  
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RESULTS AND DISCUSSION 
 
Effect of a single bout of exercise on PGC-1α protein and respiratory enzyme 
mRNAs expression in mitochondria of mouse skeletal muscle 
A 90-min bout of treadmill running induced transient PGC-1α protein expression 6 to 
12 h after exercise, with an about 1.5-fold increase (p < 0.05 compared to pre group, Fig. 
1A). This increase in PGC-1α expression returned to control levels within 24 h after 
exercise. The kinetics of the increase in PGC-1α protein is comparable to 
those in previous studies of human and rat muscle [9, 10]. 
Recent studies have indicated that PGC-1α has a pivotal role in mitochondrial 
biogenesis and that PGC-1α expression is a rate-limiting step for mitochondrial gene 
expression in skeletal muscle [10, 18, 22-24]. Therefore, we investigated temporal 
changes in the expression of respiratory enzyme (CYTC, COXIV and ATPsynβ) 
mRNAs in mouse skeletal muscle after a single 90-min bout of treadmill running. The 
exercise induced a biphasic increase in the expression of respiratory enzyme mRNAs in 
the plantaris muscle (Fig. 1B). The second phase increase (6 ~ 12 h after exercise) in 
respiratory enzyme mRNA expression was concomitant with an increase in PGC-1α 
protein expression level, but the first phase increase (1 h after exercise) showed slightly 
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but no such a clear correlation. These data suggested that skeletal muscle have another 
way to induce the expression of respiratory enzymes rather than PGC 1α expression in 
1st phase. 
It is surprising that a single bout of exercise induced a biphasic increase in the 
expression of respiratory enzyme mRNAs. Hildebrandt et al. and Pilegaard et al. 
reported that exercise stimulated the transcription of several genes expressed in 
mitochondria including pyruvate dehydrogenase kinase-4 (PDK4), uncoupling protein-3 
(UCP3) and CPT-I in rat and human, respectively [9, 25]. However, these increases 
were not biphasic. To assess whether the biphasic increase after single bout of exercise 
is specific for respiratory enzyme mRNAs, we measured the mRNA expression of 
CPT-I after single bout of exercise. As shown in Fig 1B, CPT-I mRNA was increased 6 
and 12 h after single bout of exercise (1.8-fold increase after 6 h and 1.7-fold increase 
after 12 h). The kinetics of CPT-I mRNA increase is transient as shown in previous 
studies [9, 25]. These results suggested that biphasic increase is specific to respiratory 
enzymes. The difference in post-exercise mitochondrial enzyme expression between the 
respiratory and CPT-I mRNAs might be explained for by differences in the 
transcriptional regulator involved. Several previous studies have suggested that 
transcription of respiratory enzymes is regulated by transcription factors such as, 
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Nuclear Respiratory Factor-1 and -2 (NRF-1 and 2) or Estrogen-related Receptor α [26, 
27]. On the other hand, it has been considered that expression of PDK4, UCP3 and 
CPT-I is modulated by members of the peroxisome proliferators-activated receptor 
family [28-30].  
 
Effect of inhibition of p38 MAPK activation in response to a single bout of exercise 
on expression of PGC-1α and respiratory enzymes  
Many previous reports have demonstrated that exercise or contraction activates MAPK 
signaling [21, 31-35], and that MAPK activity increases immediately after an acute bout 
of exercise [21, 34] or electrical stimulation [35]. We speculated that MAPK, especially 
p38, mediates increases in PGC-1α expression and respiratory mRNA after acute 
treadmill running. Therefore, we assessed temporal changes in p38 MAPK activity after 
acute treadmill running by kinase assay using ATF-2 Fusion Protein as a specific 
substrate of p38 MAPK in mouse skeletal muscles. Activity of p38 MAPK was 
increased 0 h after treadmill running and returned to the base level after 12 h (Fig. 2A).  
To determine whether p38 MAPK activation is required for induction of the PGC-1α 
and respiratory enzyme gene after treadmill running, mice were pretreated with SB, a 
pharmacological inhibitor of p38 MAPK, and then expression levels of 
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PGC-1α and respiratory enzyme mRNAs in the plantaris muscle were determined after 
treadmill exercise. As shown in Fig. 2A, p38 MAPK activity in the plantaris muscle was 
increased 0 h after cessation of treadmill running and this increase was inhibited about 
50 % by pretreatment with SB. This is the first report that can inhibit exercise-induced 
activation of p38 MAPK in skeletal muscle in vivo. Administration of SB also 
suppressed the exercise-related induction of PGC-1α protein expression completely in 
the plantaris muscle (12 h after exercise, Fig 2B). This result suggested that 
exercise-induced increase in PGC-1α expression required for p38 MAPK activation. As 
stated above, acute exercise induced a biphasic increase in the expression of respiratory 
enzyme mRNAs. The first phase was not concomitant with PGC-1α protein expression, 
whereas the second phase (6 and 12 h after exercise) was accompanied by an increase in 
PGC-1α protein. Administration of SB also suppressed both phase increase in 
respiratory mRNA (Fig 3). These finding suggest that p38 MAPK is a central mediator 
of exercise-induced respiratory enzyme expression in skeletal muscle. However, how 
does p38 MAPK mediate the expression of respiratory enzyme mRNAs in both phases 
of the increase? In the second phase, SB was able to inhibit the exercise-induced 
increase in PGC-1α protein. Therefore, it can be thought that p38 MAPK mediates the 
expression of respiratory enzyme mRNAs in the second phase through induction of 
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PGC-1α expression. On the other hand, it is more difficult to account for the first phase 
of the increase. One possibility is phosphorylation of PGC-1α by p38 MAPK. p38 
MAPK phosphorylates PGC-1α at three residues (T262, S265 and T298), and this 
increases the stability and half-life of the molecule [12]. Another study has 
demonstrated that p160 myb binding protein (p160MBP) binds this region (amino acids 
200-403) and represses the activity of PGC-1α as a transcriptional coactivator. When 
phosphorylated in this region, p160MBP dissociates from PGC-1α, and PGC-1α 
becomes able to bind transcriptional factors such as NRF-1 and initiate transcriptional 
activity [36, 37]. NRF-1 is an important transcription factor regulating the expression of 
mitochondrial enzymes [38, 39]. Currently, it is unknown whether exercise induces 
phosphorylation of PGC-1α via p38 MAPK pathways, and this issue will require future 
study. 
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FIGURE LEGENDS 
Figure 1  
Effect of a single bout of exercise on PGC-1α protein expression (A) and mitochondrial 
mRNA expression (B). The pre group was assigned a value of 1.0; all other values are 
expressed relative to this value. All values are reported as means ± SE (n = 6). * 
significantly different from the pre group (p < 0.05). 
Figure 2  
Administration of 25 mg/kg SB203580 inhibits exercise-induced activation of p38 
MAPK and PGC-1α expression in mouse skeletal muscle. (A) p38 MAPK kinase assay 
and (B) Western blotting using anti-PGC1 antibody. All values are reported as means 
± SE (n = 6). * significantly different from the control + saline group, # significantly 
different from the 12 h + saline group (p < 0.01). 
Figure 3  
Expression of mRNAs for CYTC, COXIV and ATPsynβ in mouse plantaris muscle. All 
values are reported as means ± SE (n = 6). * significantly different from the control + 
saline group, # significantly different from the 1 h + saline group, $ significantly 
different from the 12 h + saline group (p < 0.05). 
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